Deepcell is a fast-growing biotechnology company that leverages advanced artificial intelligence and microfluidics to analyze, classify, and isolate single cells based on their visual characteristics. Originating from research at Stanford University, Deepcell aims to enhance biomedical research, diagnostic testing, and therapeutic applications by providing a unique platform capable of processing label-free, viable cells. The company's technology addresses a broad array of challenges within the life sciences, enabling researchers to derive insights at a cellular level that were previously unattainable. With a commitment to innovation and collaboration, Deepcell fosters a diverse and inclusive workplace, believing that every employee can contribute meaningfully to the company's mission of improving health outcomes through cutting-edge scientific advancements.